Literature DB >> 19615369

Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.

Deborah A Finn1, Ethan H Beckley, Katherine R Kaufman, Matthew M Ford.   

Abstract

Alcoholism is a complex disorder that represents an important contributor to health problems worldwide and that is difficult to encompass with a single preclinical model. Additionally, alcohol (ethanol) influences the function of many neurotransmitter systems, with the interaction at gamma-aminobutyric acid(A) (GABA(A)) receptors being integral for ethanol's reinforcing and several withdrawal-related effects. Given that some steroid derivatives exert rapid membrane actions as potent positive modulators of GABA(A) receptors and exhibit a similar pharmacological profile to that of ethanol, studies in the laboratory manipulated GABAergic steroid levels and determined the impact on ethanol's rewarding- and withdrawal-related effects. Manipulations focused on the progesterone metabolite allopregnanolone (ALLO), since it is the most potent endogenous GABAergic steroid identified. The underlying hypothesis is that fluctuations in GABAergic steroid levels (and the resultant change in GABAergic inhibitory tone) alter sensitivity to ethanol, leading to changes in the positive motivational or withdrawal-related effects of ethanol. This review describes results that emphasize sex differences in the effects of ALLO and the manipulation of its biosynthesis on alcohol reward-versus withdrawal-related behaviors, with females being less sensitive to the modulatory effects of ALLO on ethanol-drinking behaviors but more sensitive to some steroid manipulations on withdrawal-related behaviors. These findings imply the existence of sex differences in the sensitivity of GABA(A) receptors to GABAergic steroids within circuits relevant to alcohol reward versus withdrawal. Thus, sex differences in the modulation of GABAergic neurosteroids may be an important consideration in understanding and developing therapeutic interventions in alcoholics. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615369      PMCID: PMC2813380          DOI: 10.1016/j.yhbeh.2009.07.002

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  115 in total

Review 1.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

Review 2.  Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas.

Authors:  Tibor Hajszan; Neil J MacLusky; Csaba Leranth
Journal:  Horm Behav       Date:  2007-12-31       Impact factor: 3.587

3.  Voluntary ethanol consumption in 22 inbred mouse strains.

Authors:  Naomi Yoneyama; John C Crabbe; Matthew M Ford; Andrea Murillo; Deborah A Finn
Journal:  Alcohol       Date:  2008-03-20       Impact factor: 2.405

4.  Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice.

Authors:  Carola Eva; Paolo Mele; Devis Collura; Antonella Nai; Maria Giuseppina Pisu; Mariangela Serra; Giovanni Biggio
Journal:  J Neurochem       Date:  2007-11-22       Impact factor: 5.372

5.  The impact of gonadectomy and adrenalectomy on acute withdrawal severity in male and female C57BL/6J and DBA/2J mice following a single high dose of ethanol.

Authors:  Katherine R Gililland; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2007-09-11       Impact factor: 3.455

6.  Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity.

Authors:  Joel G Hashimoto; Kristine M Wiren
Journal:  Neuropsychopharmacology       Date:  2007-06-27       Impact factor: 7.853

Review 7.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

Review 8.  Neuropharmacology of alcohol addiction.

Authors:  V Vengeliene; A Bilbao; A Molander; R Spanagel
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 9.  A key role for corticotropin-releasing factor in alcohol dependence.

Authors:  Markus Heilig; George F Koob
Journal:  Trends Neurosci       Date:  2007-07-16       Impact factor: 13.837

10.  Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.

Authors:  Ethan H Beckley; Andrea M Fretwell; Michelle A Tanchuck; Katherine R Gililland; John C Crabbe; Deborah A Finn
Journal:  Neuropharmacology       Date:  2007-10-22       Impact factor: 5.250

View more
  40 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

Review 2.  Applications of schedule-induced polydipsia in rodents for the study of an excessive ethanol intake phenotype.

Authors:  Matthew M Ford
Journal:  Alcohol       Date:  2014-02-28       Impact factor: 2.405

3.  Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers.

Authors:  Mehmet Sofuoglu; Maria Mouratidis; Marc Mooney
Journal:  Psychoneuroendocrinology       Date:  2010-08-02       Impact factor: 4.905

4.  Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model.

Authors:  Stacey L Robinson; Brian A McCool
Journal:  Physiol Behav       Date:  2015-05-31

5.  Voluntary wheel running attenuates ethanol withdrawal-induced increases in seizure susceptibility in male and female rats.

Authors:  Leslie L Devaud; Shawn A Walls; Walter D McCulley; Alan M Rosenwasser
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

6.  Cellular GABAergic Neuroactive Steroid (3α,5α)-3-Hydroxy-Pregnan-20-One (3α,5α-THP) Immunostaining Levels Are Increased in the Ventral Tegmental Area of Human Alcohol Use Disorder Patients: A Postmortem Study.

Authors:  Ahmet Sait Hasirci; Antoniette M Maldonado-Devincci; Matthew C Beattie; Todd K O'Buckley; A Leslie Morrow
Journal:  Alcohol Clin Exp Res       Date:  2017-01-09       Impact factor: 3.455

Review 7.  Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication?

Authors:  Asli F Ceylan-Isik; Shawna M McBride; Jun Ren
Journal:  Life Sci       Date:  2010-06-16       Impact factor: 5.037

Review 8.  Cross-Species Translational Findings in the Discriminative Stimulus Effects of Ethanol.

Authors:  Daicia C Allen; Matthew M Ford; Kathleen A Grant
Journal:  Curr Top Behav Neurosci       Date:  2018

9.  Chronic ethanol drinking increases during the luteal menstrual cycle phase in rhesus monkeys: implication of progesterone and related neurosteroids.

Authors:  Brandy L Dozier; Cara A Stull; Erich J Baker; Matthew M Ford; Jeremiah P Jensen; Deborah A Finn; Kathleen A Grant
Journal:  Psychopharmacology (Berl)       Date:  2019-01-15       Impact factor: 4.530

10.  Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

Authors:  M J Ramaker; M M Ford; T J Phillips; D A Finn
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.